BAJAJ BROKING

Notification close image
No new Notification messages
card image
Oswal Pumps IPO is Open!
Apply for the Oswal Pumps IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

13101

524394

VIMTALABS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

VIMTA LABS LIMITED performance

Today’s low

Today’s high

₹ 478.05 ₹ 508.35
₹ 482.45

52 week low

52 week high

₹ 236.03 ₹ 589.00
₹ 482.45

Open Price

₹ 508.35

Prev. Close

₹ 513.85

Volume (Shares)

187946.00

Total traded value

₹ 906.74

Upper Circuit

₹ 616.60

Lower Circuit

₹ 411.10

info

VIMTA LABS LIMITED Share Price Update

As of the latest trading session, VIMTA LABS LIMITED share price is currently at ₹ 486.2, which is down by ₹ -27.64 from its previous closing. Today, the stock has fluctuated between ₹ 478.05 and ₹ 508.35. Over the past year, VIMTA LABS LIMITED has achieved a return of 105.39 %. In the last month alone, the return has been 1.10 %. Read More...

VIMTA LABS LIMITED fundamentals


  • Market cap (Cr)

    2,148.30

  • P/E Ratio (TTM)

    33.98

  • Beta

    1.03

  • Book Value / share

    85.12

  • Return on equity

    19.44%

  • EPS (TTM)

    15.13

  • Dividend yield

    0.19%

  • Net profit/quarter (Cr)

    18.32

info icon alternate text
  • Market cap (Cr)

    2,151.20

  • P/E Ratio (TTM)

    33.98

  • Beta

    0.91

  • Book Value / share

    85.12

  • Return on equity

    19.44%

  • EPS (TTM)

    15.13

  • Dividend yield

    0.19%

  • Net profit/quarter (Cr)

    18.32

info icon alternate text

VIMTA LABS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 94.44
Operating Expense 71.06
Net Profit 18.32
Net Profit Margin (%) 19.39
Earnings Per Share (EPS) 8.22
EBITDA 34.68
Effective Tax Rate (%) 26.80
Particulars DEC 2024 (Values in Cr)
Revenue 89.92
Operating Expense 67.23
Net Profit 21.50
Net Profit Margin (%) 23.91
Earnings Per Share (EPS) 9.65
EBITDA 34.31
Effective Tax Rate (%) 26.75
Particulars SEP 2024 (Values in Cr)
Revenue 83.14
Operating Expense 62.83
Net Profit 14.59
Net Profit Margin (%) 17.54
Earnings Per Share (EPS) 6.58
EBITDA 29.63
Effective Tax Rate (%) 22.09
Particulars JUN 2024 (Values in Cr)
Revenue 73.32
Operating Expense 56.69
Net Profit 11.64
Net Profit Margin (%) 15.87
Earnings Per Share (EPS) 5.25
EBITDA 25.69
Effective Tax Rate (%) 23.39
Particulars MAR 2024 (Values in Cr)
Revenue 72.73
Operating Expense 55.19
Net Profit 12.35
Net Profit Margin (%) 16.98
Earnings Per Share (EPS) 5.58
EBITDA 26.31
Effective Tax Rate (%) 22.18
Particulars MAR 2025 (Values in Cr)
Revenue 343.98
Operating Expense 259.21
Net Profit 67.34
Net Profit Margin (%) 19.57
Earnings Per Share (EPS) 30.28
EBITDA 126.19
Effective Tax Rate (%) 25.00
Particulars MAR 2024 (Values in Cr)
Revenue 288.60
Operating Expense 229.79
Net Profit 41.01
Net Profit Margin (%) 14.20
Earnings Per Share (EPS) 18.52
EBITDA 97.74
Effective Tax Rate (%) 21.90
Particulars MAR 2023 (Values in Cr)
Revenue 315.12
Operating Expense 254.75
Net Profit 47.30
Net Profit Margin (%) 15.01
Earnings Per Share (EPS) 21.37
EBITDA 97.00
Effective Tax Rate (%) 25.89
Particulars MAR 2022 (Values in Cr)
Revenue 275.98
Operating Expense 220.87
Net Profit 41.06
Net Profit Margin (%) 14.87
Earnings Per Share (EPS) 18.57
EBITDA 80.01
Effective Tax Rate (%) 25.81
Particulars MAR 2021 (Values in Cr)
Revenue 209.05
Operating Expense 181.47
Net Profit 21.26
Net Profit Margin (%) 10.16
Earnings Per Share (EPS) 9.62
EBITDA 53.51
Effective Tax Rate (%) 25.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 144.20
ROE % 13.64
ROCE % 16.99
Total Debt to Total Equity 0.06
EBITDA Margin 28.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 127.33
ROE % 18.68
ROCE % 23.48
Total Debt to Total Equity 0.07
EBITDA Margin 30.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.83
ROE % 19.30
ROCE % 22.76
Total Debt to Total Equity 0.12
EBITDA Margin 28.93
Particulars MAR 2021 (Values in Cr)
Book Value / Share 87.92
ROE % 11.66
ROCE % 13.58
Total Debt to Total Equity 0.17
EBITDA Margin 25.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 78.19
ROE % 3.96
ROCE % 5.58
Total Debt to Total Equity 0.19
EBITDA Margin 18.24
Particulars MAR 2025 (Values in Cr)
Book Value / Share 170.38
ROE % 19.44
ROCE % 24.14
Total Debt to Total Equity 0.04
EBITDA Margin 36.86
Particulars MAR 2024 (Values in Cr)
Book Value / Share 141.69
ROE % 13.66
ROCE % 19.43
Total Debt to Total Equity 0.06
EBITDA Margin 33.68
Particulars MAR 2023 (Values in Cr)
Book Value / Share 126.79
ROE % 18.40
ROCE % 23.15
Total Debt to Total Equity 0.07
EBITDA Margin 30.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 105.68
ROE % 19.19
ROCE % 22.69
Total Debt to Total Equity 0.11
EBITDA Margin 28.99
Particulars MAR 2021 (Values in Cr)
Book Value / Share 87.89
ROE % 11.58
ROCE % 13.56
Total Debt to Total Equity 0.17
EBITDA Margin 25.59
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.78
Total Assets 400.05
Total Liabilities 400.05
Total Equity 319.69
Share Outstanding 22170583
Price to Book Ratio 3.14
Return on Assets (%) 10.25
Return on Capital (%) 12.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 39.77
Total Assets 362.32
Total Liabilities 362.32
Total Equity 281.78
Share Outstanding 22128989
Price to Book Ratio 2.48
Return on Assets (%) 13.29
Return on Capital (%) 16.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.41
Total Assets 307.19
Total Liabilities 307.19
Total Equity 233.98
Share Outstanding 22107810
Price to Book Ratio 2.98
Return on Assets (%) 13.45
Return on Capital (%) 16.32
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.79
Total Assets 274.35
Total Liabilities 274.35
Total Equity 194.38
Share Outstanding 22107810
Price to Book Ratio 1.83
Return on Assets (%) 7.80
Return on Capital (%) 9.52
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.67
Total Assets 245.76
Total Liabilities 245.76
Total Equity 172.87
Share Outstanding 22107810
Price to Book Ratio 0.76
Return on Assets (%) 2.78
Return on Capital (%) 3.49
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 32.94
Total Assets 466.53
Total Liabilities 466.53
Total Equity 378.84
Share Outstanding 22234512
Price to Book Ratio 5.87
Return on Assets (%) 14.43
Return on Capital (%) 17.38
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 25.78
Total Assets 394.47
Total Liabilities 394.47
Total Equity 314.11
Share Outstanding 22170583
Price to Book Ratio 3.14
Return on Assets (%) 10.39
Return on Capital (%) 12.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 38.82
Total Assets 360.47
Total Liabilities 360.47
Total Equity 280.58
Share Outstanding 22128989
Price to Book Ratio 2.48
Return on Assets (%) 13.12
Return on Capital (%) 16
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 11.27
Total Assets 306.23
Total Liabilities 306.23
Total Equity 233.64
Share Outstanding 22107810
Price to Book Ratio 2.98
Return on Assets (%) 13.40
Return on Capital (%) 16.25
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.61
Total Assets 273.07
Total Liabilities 273.07
Total Equity 194.31
Share Outstanding 22107810
Price to Book Ratio 1.83
Return on Assets (%) 7.78
Return on Capital (%) 9.49
Particulars MAR 2024 (Values in Cr)
Net Income 54.48
Cash from Operations 76.36
Cash from Investing -76.04
Cash from Financing -1.90
Net change in Cash -17.05
Free Cash Flow 152.69
Particulars MAR 2023 (Values in Cr)
Net Income 64.99
Cash from Operations 100.46
Cash from Investing -57.25
Cash from Financing -10.98
Net change in Cash 19.70
Free Cash Flow 148.28
Particulars MAR 2022 (Values in Cr)
Net Income 55.68
Cash from Operations 75.70
Cash from Investing -37.84
Cash from Financing -16.61
Net change in Cash 4.60
Free Cash Flow 105.49
Particulars MAR 2021 (Values in Cr)
Net Income 28.54
Cash from Operations 44.39
Cash from Investing -31.92
Cash from Financing -4.57
Net change in Cash 0.68
Free Cash Flow 77.47
Particulars MAR 2020 (Values in Cr)
Net Income 8.27
Cash from Operations 30.53
Cash from Investing -20.84
Cash from Financing -0.66
Net change in Cash 2.83
Free Cash Flow 46.33
Particulars MAR 2025 (Values in Cr)
Net Income 90.40
Cash from Operations 116.62
Cash from Investing -75.53
Cash from Financing -16.68
Net change in Cash 2.39
Free Cash Flow 195.69
Particulars MAR 2024 (Values in Cr)
Net Income 54.48
Cash from Operations 76.36
Cash from Investing -76.04
Cash from Financing -1.90
Net change in Cash -17.05
Free Cash Flow 152.69
Particulars MAR 2023 (Values in Cr)
Net Income 63.83
Cash from Operations 98.74
Cash from Investing -56.92
Cash from Financing -10.66
Net change in Cash 18.92
Free Cash Flow 146.52
Particulars MAR 2022 (Values in Cr)
Net Income 55.34
Cash from Operations 75.24
Cash from Investing -37.88
Cash from Financing -16.14
Net change in Cash 4.64
Free Cash Flow 104.96
Particulars MAR 2021 (Values in Cr)
Net Income 28.39
Cash from Operations 44.17
Cash from Investing -31.87
Cash from Financing -4.57
Net change in Cash 0.52
Free Cash Flow 76.83
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.80 69.54 12.25 100545.73 6002.15 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 72.50 345.24 4.50 135.88 51.01 / 98.70
SHREE PACETRONIX LTD. 79.46 38.20 2.07 28.60 61.11 / 245.00
TRANSGENE BIOTEK LTD. 4.25 0.00 3.21 32.20 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.80 77.56 11.51 100545.73 6002.15 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 35.14 0.00 -13.88 26.25 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5937.00 31.09 5.97 6495.08 4067.50 / 6400.00

VIMTA LABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
482.70 -6.06 redarrow
red-green-graph indicator
13 Bearish
3 Bullish
  • 5 Days 495.20
  • 26 Days 491.90
  • 10 Days 489.70
  • 50 Days 493.00
  • 12 Days 489.40
  • 100 Days 478.70
  • 20 Days 490.70
  • 200 Days 433.80
515.28 PIVOT

First Support

501.67

First Resistance

527.47

Second Support

489.48

Second Resistance

541.08

Third Support

475.87

Third Resistance

553.27

RSI

58.54

ADX

11.90

MACD

-2.44

Williams % R

-23.83

Commodity Channel Index (CCI)

117.60

Date

2025-06-13

Week

79791.00

Same Day

109273.00

Month

53965.00

1 Year

1.04

3 Year

0.93

Over 1 Month

1.10%

down

Over 1 Year

105.39%

down

Over 3 Months

1.05%

down

Over 3 Years

46.23%

down

Over 6 Months

7.49%

down

Over 5 Years

66.29%

down

VIMTA LABS LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
58.2%
Promoter Holdings
36.7%
FII
3.66%
DII
1.43%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Eurofins Analytical Services India Pvt Ltd 4403668.0 (19.81%) Public Shareholding
Sivalinga Prasad Vasireddi 2598525.0 (11.69%) Shareholding of Promoter and Promoter Group
Lcgc Chromatography Solutions Private Limited 2083175.0 (9.37%) Public Shareholding
Vangal Harriman 1772818.0 (7.97%) Shareholding of Promoter and Promoter Group
Vasireddi Veerabhadra Prasad 1463515.0 (6.58%) Shareholding of Promoter and Promoter Group
Praveena Vasireddi 1102535.0 (4.96%) Shareholding of Promoter and Promoter Group
Andhra Pradesh Industrial Development Corporation Limited 590000.0 (2.65%) Shareholding of Promoter and Promoter Group
Barca Global Master Fund Lp 506622.0 (2.28%) Public Shareholding
Harita Vasireddi 167964.0 (0.76%) Shareholding of Promoter and Promoter Group
Sireesh Chandra Vungal 113055.0 (0.51%) Shareholding of Promoter and Promoter Group
Swarna Latha Vasireddi 101535.0 (0.46%) Shareholding of Promoter and Promoter Group
Sudheshna Vungal 100879.0 (0.45%) Shareholding of Promoter and Promoter Group
Vungal Rajeswari 80725.0 (0.36%) Shareholding of Promoter and Promoter Group
Sujani Vasireddi 66325.0 (0.3%) Shareholding of Promoter and Promoter Group
Rajya Lakshmi Vasireddi 2300.0 (0.01%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

VIMTA LABS LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Jun 2023 2.0 Final 22 Jun 2023 Equity shares
16 Jun 2022 2.0 Final 18 Jun 2022 Equity shares
25 Jun 2021 2.0 Final 28 Jun 2021 Equity shares
18 Jul 2019 2.0 Final 22 Jul 2019 Equity shares
14 Aug 2018 2.0 Final 20 Aug 2018 Equity shares
25 Aug 2016 1.0 Final 29 Aug 2016 Equity shares
06 Aug 2015 1.0 Final 10 Aug 2015 Equity shares
27 Jun 2014 2.0 Final 01 Jul 2014 Equity shares
23 May 2013 0.6 Final 27 May 2013 Equity shares
15 Sep 2011 0.4 Final 19 Sep 2011 Equity shares
23 Sep 2010 0.8 Final 27 Sep 2010 Equity shares
10 Sep 2009 0.8 Final 14 Sep 2009 Equity shares
28 Aug 2008 0.8 Final 01 Sep 2008 Equity shares
02 Aug 2007 0.8 Final 06 Aug 2007 Equity shares
01 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
19 May 2005 0.0 Final 23 May 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
24 Feb 2006 10.0 2.0 03 Mar 2006
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
11 Jul 2024 2.0 Final 12 Jul 2024 Equity shares
21 Jun 2023 2.0 Final 22 Jun 2023 Equity shares
16 Jun 2022 2.0 Final 18 Jun 2022 Equity shares
25 Jun 2021 2.0 Final 28 Jun 2021 Equity shares
18 Jul 2019 2.0 Final 22 Jul 2019 Equity shares
14 Aug 2018 2.0 Final 20 Aug 2018 Equity shares
25 Aug 2016 1.0 Final 29 Aug 2016 Equity shares
06 Aug 2015 1.0 Final 10 Aug 2015 Equity shares
27 Jun 2014 2.0 Final 01 Jul 2014 Equity shares
23 May 2013 0.6 Final 27 May 2013 Equity shares
15 Sep 2011 0.4 Final 19 Sep 2011 Equity shares
23 Sep 2010 0.8 Final 27 Sep 2010 Equity shares
10 Sep 2009 0.8 Final 14 Sep 2009 Equity shares
28 Aug 2008 0.8 Final 01 Sep 2008 Equity shares
02 Aug 2007 0.8 Final 06 Aug 2007 Equity shares
01 Jun 2006 0.0 Final 01 Jan 0001 Equity shares
19 May 2005 0.0 Final 23 May 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
24 Feb 2006 10.0 2.0 03 Mar 2006

VIMTA LABS LIMITED Share Price

Vimta Labs Limited., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia.

During 2002, the company began to offer Clinical Diagnostics Services. Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects. Facilities were created in the year 2000 to speed up the clinical trials.

During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S.P.Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006.

During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company.

In 2024-25, Emtac Laboratories Pvt. Ltd., the 100% owned subsidiary got merged with the Company effective from 01 April, 2024, thereby consolidating its presence in the Electronics and Electrical testing.

Parent organization Indian Private
NSE symbol VIMTALABS
Founded 1990
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Vimta Labs Ltd?

Answer Field

The share price of Vimta Labs Ltd for NSE is ₹ 486.20 and for BSE is ₹ 485.95.

What is the Market Cap of Vimta Labs Ltd?

Answer Field

The market cap of Vimta Labs Ltd for NSE is ₹ 1,077.93 Cr. and for BSE is ₹ 1,077.38 Cr. as of now.

What is the 52 Week High and Low of Vimta Labs Ltd?

Answer Field

The 52 Week High and Low of Vimta Labs Ltd for NSE is ₹ 589.00 and ₹ 236.03 and for BSE is ₹ 591.50 and ₹ 233.25.

How to Buy Vimta Labs Ltd share?

Answer Field

You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vimta Labs Ltd?

Answer Field

The 1 year returns on the stock has been 105.39%.

What is the Current Share Price of Vimta Labs Ltd?

Answer Field

Vimta Labs Ltd share price is for NSE ₹ 486.20 & for BSE ₹ 485.95 as on Jun 16 2025 02:58 PM.

What is the Market Cap of Vimta Labs Ltd Share?

Answer Field

The market cap of Vimta Labs Ltd for NSE ₹ 1,077.93 & for BSE ₹ 1,077.38 as on Jun 16 2025 02:58 PM.

What is the P/E Ratio of Vimta Labs Ltd Share?

Answer Field

As on Jun 16 2025 02:58 PM the price-to-earnings (PE) ratio for Vimta Labs Ltd share is 33.98.

What is the PB ratio of Vimta Labs Ltd Share?

Answer Field

As on Jun 16 2025 02:58 PM, the price-to-book (PB) ratio for Vimta Labs Ltd share is 85.12.

How to Buy Vimta Labs Ltd Share?

Answer Field

You can trade in Vimta Labs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vimta Labs Ltd Share on Bajaj Broking App?

Answer Field

To buy Vimta Labs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vimta Labs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|